FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal

Due to the increasing prevalence of pathogenic fungal infections, the emergence of antifungal resistant clinical isolates worldwide, and the limited arsenal of available antifungals, developing new antifungal strategies is imperative. In this study, we screened a library of 1068 FDA-approved drugs t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Yikun, Jiang, Tong, Zou, Yun, Wang, Yuanyuan, Zhou, Jia, Li, Jinyang, Liu, Lin, Tan, Jingcong, Wei, Luqi, Li, Jingquan, Dai, Huanqin, Peng, Yibing, Zhang, Lixin, Lopez-Ribot, Jose L., Shapiro, Rebecca S., Chen, Changbin, Liu, Ning-Ning, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283467/
https://www.ncbi.nlm.nih.gov/pubmed/32582050
http://dx.doi.org/10.3389/fmicb.2020.00996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283467/
https://www.ncbi.nlm.nih.gov/pubmed/32582050
http://dx.doi.org/10.3389/fmicb.2020.00996

Ejemplares similares